OHRP: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 05/15/2015 settlement date, and Ohr Pharmaceutical, Inc. ( OHRP) is one of the most shorted stocks of the Russell 3000, based on 10.41 "days to cover" versus the median component at 5.60. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

In the case of Ohr Pharmaceutical, Inc. ( OHRP), the total short interest at the 05/15/2015 settlement date was 2,494,796 shares, which compares to the average daily trading volume of just 239,730 shares, for a "days to cover" ratio of 10.41.

When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single OHRP share traded represented a short position being closed, then at the average daily volume of 239,730 shares it would only be during the 11th trading day that every short position would be closed.

So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 11 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.

Ohr Pharmaceutical, Inc. ( OHRP) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, OHRP has seen 4 different instances of insider buying, as summarized by the table below:

Purchased Insider Title Shares Price/Share Value
02/06/2015 Irach B. Taraporewala Chief Executive Officer 3,705 $6.75 $25,008.75
02/06/2015 June Sherie Almenoff Director 6,000 $6.75 $40,500.00
02/06/2015 Samuel Backenroth Chief Financial Officer 1,500 $6.75 $10,125.00
02/06/2015 Jason Scott Slakter Director 29,630 $6.75 $200,002.50

Below is a chart showing the "days to cover" for OHRP over time:

Loading+chart++2015+TickerTech.com

And looking at the chart below, OHRP's low point in its 52 week range is $2.48 per share, with $12.31 as the 52 week high point — that compares with a last trade of $2.73.

Ohr Pharmaceutical, Inc.  Moving Averages Chart

In recent trading, shares of Ohr Pharmaceutical, Inc. ( OHRP) were changing hands at $2.73/share.

If you liked this article you might like

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

Ohr Pharma (OHRP) Stock Surges After Launching Phase 3 Trial

Ohr Pharma (OHRP) Stock Surges After Launching Phase 3 Trial

8 Stocks Under $10 Making Big Moves Higher

8 Stocks Under $10 Making Big Moves Higher

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves